|
MechanismIL1R1 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Beijing Beiyi United Bioengineering Company
0 Patents (Medical) associated with Beijing Beiyi United Bioengineering Company
100 Deals associated with Beijing Beiyi United Bioengineering Company
100 Translational Medicine associated with Beijing Beiyi United Bioengineering Company